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INTRODUCTION
The number of patients with chronic kidney disease (CKD) in
Japan exceeds 13 million, of which over 300,000 require dialysis.
Renal transplantation becomes necessary with the progress of
nephropathy (1), and therefore, early detection and treatment is
critical. Diabetic nephropathy is the leading cause of CKD, and is
caused by microangiopathy and hypertension due to an increase in
circulating blood volume. With the progress in diabetes, the
glomerular filtration rate (GFR) decreases and albumin is ex-
creted in the urine. In addition, a negative cycle occurs, in which the
load on the kidney increases due to a decrease in GFR and renal
function deteriorates.
Mitochondria, which supply cellular energy and are involved in
metabolism, are important subcellular organelles. Mitochondria
have outer and inner membranes composed of phospholipids. The
matrix, which is the space within the inner membrane, contains the
enzymes required for important metabolic pathways such as the
tricarboxylic acid cycle (TCA cycle) and beta-oxidation. Electrons
from NADH and FADH2, which are derived from glycolysis or the
TCA cycle, are transferred to the mitochondrial respiratory chain.
These electrons participate in redox reactions in the mitochondrial
respiratory complexes I, III, IV or complexes II, III, IV in the inner
membrane of the mitochondria. In complex V (ATP synthase),
ADP is converted to ATP by utilizing the energy of transfer of the
hydrogen ions accumulated in the intermembrane space. Com-
plexes I and III transfer electrons to CoQ and cytochrome c, respec-
tively, and produce water by transferring electrons to oxygen mole-
cules. Reactive oxygen species (ROS) are generated by the one-
electron reduction of oxygen molecules with the electrons from
complexes I and III. ROS is reduced to water by the antioxidative
activity of glutathione peroxidase and peroxiredoxin. However, if
the balance of excessive ROS and antioxidative capacity is dis-
rupted, ROS levels increase, which subsequently causes mitochon-
drial oxidative stress. Oxidative stress irreversibly damages the
mitochondrial constituents and leads to cell death. Therefore, mito-
chondrial dysfunction has been associated with various diseases.
Lee’s syndrome is a disease caused by disorders of complex I-V.
Also, agrochemical rotenone inhibits complex I. Symptoms of
Parkinson’s disease are similar to those of rotenone poisoning,
and is considered to be caused by complex inhibition. Further-
more, since complex I and III are involved in the production of
superoxide, mitochondrial dysfunctions have a high frequency of
oxidative stress(2, 3).
It is suggested that mitochondrial dysfunction is involved in the
onset and progression of diabetic nephropathy in humans. ROS
levels in bovine vascular endothelial cells are related to glucose
concentration (4). We reported that thioredoxin 1, which plays an
important role in the regulation of intracellular redox balance,
markedly suppressed oxidative stress in the kidney of streptozotocin
(STZ)- induced diabetic mice and ameliorated characteristic patho-
physiological changes of diabetic nephropathy (5). STZ-induced
diabetic rats in the early stage of the disease have increased mito-
chondrial ROS levels and decreased renal complex III activity (6). In
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the kidney of diabetic mice, the activities of complexes I and III
increased (7) and the protein levels of complexes I and III in-
creased (8). Furthermore, Zhang et al. consider that the noncon-
cordance of each complex in renal mitochondria of db/db mice is
involved in ROS overproduction and oxidative stress in diabetes
(8). Hyperglycemia causes hyperosmolarity, which leads to trans-
port of water from within the cell to the extracellular space and
increases renal water reabsorption. As a result, circulating blood
volume and blood pressure increase. Therefore, in renal pathology
of diabetes, it is difficult to distinguish between changes caused
by diabetes or hypertension.
Hypertension is generally associated with glomerular hyperten-
sion (9). In spontaneously hypertensive rats (SHR), mitochondrial
ROS is suggested to increase (10). Hypertension induces decrease
of oxidative phosphorylation rate in the kidney of SHR (11). This
result shows that oxidative stress due to glomerular hyperfiltration
causes dysfunction of the renal mitochondrial respiratory com-
plexes. However, Tapia et al. reports that antioxidative enzyme ac-
tivity in 5/6 nephrectomized rats, a model of glomerular hyperfil-
tration, decreased, but mitochondrial oxygen consumption does
not change (12). Therefore, the influence of glomerular hyperfiltra-
tion on mitochondrial function is still unknown.
The effects of hypertension have to be verified to understand the
mechanism of development and progression of diabetic nephropa-
thy. In this study, we examined the influence of glomerular hy-
perfiltration in renal mitochondrial complexes of a 5/6 nephrec-
tomized (5/6Nx) BKS.Cg-Dock7m+/+Leprdb/J, Dock7m+/+Leprdb
mouse without diabetes. BKS.Cg-Dock7m+/+Leprdb/J, +Leprdb/+
Leprdb mouse which is murine model of spontaneous type 2 diabetes
and found renal oxidative stress (13) was used for the positive
control.
MATERIALS AND METHODS
Animals
Fifty male 7-week-old BKS.Cg-Dock7m+/+Leprdb/J, Dock7m+/+
Leprdb mice (db/mmice) and 20male BKS.Cg-Dock7m+/+Leprdb/J,
+Leprdb/+Leprdb mice(db/db mice) were purchased from Charles
River Laboratories, Japan (Kanagawa, Japan). The mice were
individually housed in polycarbonate cages with bedding. The
environmental conditions of the animal room were as follows :
room temperature, 21.424.3 ; relative humidity, 4372% ; air
exchange, 625 times/h ; and a 12 h light/dark cycle (lights on at 7
AM and off at 7 PM). The mice were allowed free access to solid
feed (CE-2 gamma irradiated ; CLEA Japan, Tokyo, Japan) and tap
water.
db/m mice with spontaneous pyelectasia were detected by ultra-
sonography (Applied XG ; Toshiba Medical Systems, Tochigi,
Japan) and were excluded from the experiment.
5/6Nx and sham operations were performed using the following
procedure. First, two-thirds (upper side, lower side, and outside of
the left kidney) were removed from 8-week-old db/m mice while
ligating the renal artery, renal vein, and urinary duct. Next, the
right kidney was completely excised after 2 weeks (db/m-5/6Nx
mice). Sham operation was performed on the left and right sides of
the abdomen in db/m mice at 8 and 10 weeks of age, respectively.
The sameprocedures were performed for the sham operation with
the exception of ischemia and nephrectomy (db/m-sham mice).
Table 1 shows the experimental design.
Table 2 shows the body weight at necropsy. In db/db mice, the
inhibition of body weight gain or decrease of body weight with
aging agreed with previously report (14).
The care and use of the animals and experimental protocols
used in this study were approved by the Experimental Animal Care
and Use Committee of Takeda Pharmaceutical Company Limited
(Kanagawa, Japan). Animals with poorer performance status were
euthanized according to the protocol and not used in this experi-
ment.
Measurement of blood creatinine/urea nitrogen/glucose levels
Blood was collected from the posterior vena cava under isoflu-
rane anesthesia with a syringe containing heparin sodium. Blood
was centrifuged at 7,500 × g for 10 min, and plasma was analyzed
using an automated analyzer (LABOSPECT 008 ; Hitachi High-
Technologies Corporation, Tokyo, Japan) and standard reagents
(Wako Pure Chemical Industries, Osaka, Japan).
Histopathology
The left kidney was excised from sacrificed animals after exsan-
guination. Next, a part of the left kidney was fixed with 10% (v/v)
neutral -buffered formalin solution. The remaining kidney was im-
mediately frozen in liquid nitrogen and stored at -80 until further
use. The fixed left kidney was embedded in paraffin, and cut into
sections. The sections were stained with hematoxylin and eosin
and periodic acid-Schiff (PAS) stain for assessing glomerular
changes. The expansion of the mesangial matrix was assessed by
analyzing the intensity and distribution of the lesions for each
glomerulus.
Preparation of renal mitochondria
Mitochondria were prepared from the cryopreserved kidneys
using a mitochondria isolation kit for tissues (Abcam, Cambridge,
United Kingdom). Protein content was measured using the bicin-
choninic acid (BCA) protein assay kit (ThermoFisher, Waltham,
Massachusetts, United States). The solution was adjusted to 6.0 mg/
mL with homogenates containing a protease inhibitor (Sigma-
Aldrich, St. Louis, Missouri, United States) and stored at -80 until
further use.
Table1. Experimental design
A
16-17 weeks 24-26 weeks
of age at necropsy of age at necropsy
(6 -7 weeks after surgery) (14 -16 weeks after surgery)
db/m-Sham mice N=7 N=11
db/m-5/6Nx mice N=11 N=21
B
13 weeks of age 16 -17 weeks of age 21 weeks of age
at necropsy at necropsy at necropsy
db/db mice N=6 N=11 N=3
Table2. Body weight at necropsy
A
16-17 weeks of age 24-26 weeks of age
db/m-Sham mice 30.01.3 32.71.9
db/m-5/6Nx mice 28.61.8 30.71.1
B
13 weeks of age 16 -17 weeks of age 21 weeks of age
db/db mice 50.43.4 41.95.1 41.73.8
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Determination of adenosine triphosphate (ATP) content in the
kidney
A part of the kidney homogenized for mitochondrial preparation
was used for measurement of ATP content using a luminometer
(Sirius L Single Tube Luminometer ; Titertek Berthold, Bad Wild-
bad, Germany) and a reagent kit purchased from Toyo B-net
(Tokyo, Japan).
Determination of mitochondrial DNA content in the kidney
The quantity of mitochondrial DNA (mtDNA) relative to the
amount of nuclear DNA (nDNA) was determined. A QIAamp
DNA mini kit (Qiagen, Valencia, California, United States) was
used for extraction of mitochondrial DNA and nuclear DNA.
DNA content was measured using a NanoDrop ND-8000 (Ther-
moFisher), and each sample was adjusted to 100 ng/mL and
stored at -80until further use. A 7600 HT real - time polymerase
chain reaction (PCR) instrument (Applied Biosystems, Foster City,
California, United States) was used for quantitative PCR with
SYBRGreen PCR master mix (ThermoFisher). Primers were
prepared as previously described and are mentioned below (15,
16) :
mitochondrial D-Loop, forward 5’ -AATCTACCATCCTCCGTG-3’
and reverse 5’ -GACTAATGATTCTTCACCGT-3’ ;
nuclear β -actin, forward 5’ -AGCCATGTACGTAGCCATCCA-3’
and reverse 5’ -TCTCCGGAGTCCATCACAATG-3’.
PCR conditions were as follows : initial denaturation at 95for
10 s, followed by 40 cycles of denaturation at 95for 15 s and
annealing/extension at 60for 1 min. Melting curve analysis was
performed at 95for 15 s followed by 60for 1 min. Samples for
calibration curves were extracted and stored in advance from the
kidneys of db/m mice using the same method. A calibration curve
was prepared for each measurement and the ratio of mtDNA to
nDNA was calculated.
Assessment of complex activities
The activities of complexes I and IV were measured using a ro-
dent enzyme activity microplate assay kit (Abcam). Each activity
level was calculated as a ratio of bovine cardiac mitochondria
(Abcam).
Assessment of complex protein levels
The solubilized mitochondria and the bovine heart mitochondria
(Abcam) with the surfactant were fractionated into each complex
using the native page TM bis- tris gel system (BN-PAGE ; Invitro-
gen, California, United State) with 312% bis- tris protein gels, 1.0
mm (Invitrogen). Protein was transferred from the electrophoresis
gel onto a PVDF (polyvinylidene fluoride) membrane by electroblot-
ting. Each protein was immunodetected using specific antibodies.
An ImageQuant LAS 4000 (GE Healthcare Japan, Tokyo, Japan)
was used for measurement, and the value of each sample was
calculated as a ratio relative to that of the bovine heart mitochon-
dria. The western blotting detection reagents were purchased from
GE Healthcare.
The following primary antibodies were purchased from Abcam :
complex I, anti -NDUFA9 (20C11B11B11) ; complex II, anti -SDHA
(2E3GC12FB2AE2) ; complex III, anti -UQCRC2 (13G12AF12BB
11) ; complex IV, anti -COX IV (20E8C12) ; complex V, anti -ATP5A
(15H4C4). The secondary antibody used was anti mouse IgG-
horse radish peroxidase (HRP) (GE Healthcare).
Statistical analyses
Measurement data were analyzed as follows. The F-test was first
performed for determining the homogeneity of variance between
the groups. The Student’s t - test was used when the variances were
homogeneous, and the Aspin and Welch t- test was performed to
compare the mean in the control group with that in the dosage
group when the variances were heterogeneous. The F-test was
conducted at the one-tailed significance level of 0.20, and the other
tests were conducted at the two-tailed significance levels of 0.05
and 0.01. The SAS system version 8.2 was used for statistical
analyses.
RESULTS
Blood creatinine/urea nitrogen/glucose levels
In the db/m-5/6Nx group, the creatinine and urea nitrogen
levels were significantly increased at 16-17 and 24-26 weeks of age
(Figs. 1A and 1B). To investigate the influence of the onset period of
diabetes, in the db/db group, 16-17 and 21 weeks of age were com-
pared to 13 weeks of age animals. The creatinine and urea nitrogen
levels of the db/db group did not change (Figs. 1C and 1D). It is
likely that creatinine and urea nitrogen did not increase in this
study, because reports show that the glucose level in db/db mouse
starts to increase by 6 weeks, and blood creatinine and urea nitro-
gen levels increased after sustained hyperglycemia for 10 weeks
(17).
Blood glucose levels were measured for verification of non-
diabetic condition (22418 vs 22226 at 16-17 weeks of age,
23127 vs 22018 mg/dL at 24-26 weeks of age in db/m-
Sham vs db/m-5/6Nx group, respectively). Similarly, glucose
levels of the db/db group were 80791, 740144, and 85461
mg/dL at 13, 16-17 weeks and 21 weeks of age, respectively.
Fig.1. Blood creatinine and urea nitrogen levels.
Levels of creatinine (A) and urea nitrogen (B) in db/m-5/6Nx group
increased compared to those in db/m-sham group at 16 -17 weeks of age
and 24-26 weeks of age. Creatinine (C) and urea nitrogen (D) in db/db
group did not change compared to those at 13 weeks of age. Data are
shown as meansstandard deviation (SD). N.S., not significant, *, p
0.05or**,p0.01.
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Histopathology
Table 3 shows the histopathological findings of the kidney. Expan-
sion of the mesangial matrix in glomeruli was noted in db/m-5/6
Nx mice at 16-17 and 24-26 weeks of age (Figs. 2B and 2D), and
these changes were thought to be associated with nephrectomy.
The distribution of the glomerular lesions tended to expand in
24-26 weeks of age compared to that in 16-17 weeks of age. The
severities in the changes in individual glomeruli were worse in
24-26 weeks of age than in 16-17 weeks of age. Moreover, slight
basophilic renal tubules and dilation of the distal tubules or col-
lecting ducts was observed in the 5/6Nx-db/m groups. No
glomerular and tubular lesions were observed in the db/m-sham
groups.
ATP content
There was no significant difference in ATP content between the
db/m-5/6Nx group and db/m-sham group (Fig. 3A). However, in
the db/db group, there was significant but marginal difference in
ATP content between 16-17 and 21, and 13 weeks of age (Fig. 3B).
Mitochondrial DNA content
In the db/m-5/6Nx group, there was no significant difference in
the renal mitochondrial content compared to the db/m-sham
group (Fig. 4A). Similar result was obtained for the db/db group
(Fig. 4B).
Complex activities
Complex IV activity in the db/m-5/6Nx group animals that were
16-17 weeks of age decreased significantly compared to those in
Table3. Histopathological findings of the kidney
16 -17 weeks of age 24 -26 weeks of age
m/db 5/6NX (# examined) 11 21
Expansion, mesangial matrix - in kidney 6/1/0 13/4/1
Severity of the glomerular lesion 6/1/0 11/8/0
Dilation, tubule 4/0/0 5/1/0
Tubular basophilia 7/1/0 10/0/0
/+/++,: Minimal,+ : Mild,++ : Moderate
Fig.2. Representative glomerular changes.
Periodic acid -Schiff staining of glomeruli. db/m-sham mice (A) and
db/m-5/6 nephrectomized mice (B) at 16 -17 weeks of age. db/m-sham
mice (C) and db/m-5/6 nephrectomized mice (D) at 24 -26 weeks of age.
Expansion of the mesangial matrix is shown in figures 2B and 2D.
(Bar =50µm)
Fig.3. Renal ATP content.
The concentration of ATP is converted to rate per 1 g of kidney tissue.
The ATP content of the db/m-5/6Nx group was not different from
that of the db/m-sham group (A). The db/db group showed slight
increase in ATP content compared to that of 13 -weeks-old mice (B). Data
are shown as meansSD. N.S., not significant, *, p0.05 or **, p
0.01. Data are shown as meansSD. *, p0.05.
Fig.4. Mitochondrial DNA contents of the kidney.
The quantity of mitochondrial DNA (mtDNA) relative to the amount of
nuclear DNA (nDNA) has been plotted against the age of the animals.
mtDNA/nDNA in the db/m-5/6Nx group was not different from that of
the db/m-sham group (A). mtDNA/nDNA of the db/db group did not
change with the age of the animals (B). N.S., not significant. Data are
shown as meansSD.
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animals of same age in the db/m-sham group. The activities of
complexes I and IV in 24-26 weeks of age decreased significantly
compared to those in animals of same age in the db/m-sham group
(Fig. 5A and 5B). Furthermore, complex I activity in 16-17-weeks-
old db/db group animals decreased and complex V activity signifi-
cantly increased compared to corresponding activities in 13 weeks-
old-animals. The complex activities were similar between 16-17
weeks- and 21 weeks-old animals of the db/db group (Fig. 5C
and 5D).
Complex protein levels
Complex I and III protein levels in 24-26 weeks-old animals of
the db/m-5/6Nx group decreased significantly compared to those
of the db/m-sham group. The protein levels of other complexes
were not significantly different at other ages (Fig. 6A). In the db/db
group, complex III and IV protein levels at 16-17 weeks and 21
weeks decreased significantly, and these changes were compara-
ble. There was a transient increase in levels of complex I in 16-17-
week-old animals compared to their levels in 13 weeks. The
levels of complex II decreased significantly only in 21 week-old
mice. The levels of complex V did not differ from that of 13 week-old
animals at any age (Fig. 6B).
DISCUSSION
The capillary vessels of the glomerulus experience excessive
pressure in hypertension. Consequently, this causes glomerular
hyperfiltration and increases the glomerular mesangial matrix
(18). In this study, increase of the glomerular mesangial matrix was
observed by histopathological examination of the kidneys of
db/m-5/6Nx mouse, which was suggestive of glomerular hyperfil-
tration. However, db/m-5/6Nx mouse were considered to repre-
sent the earliest stage of nephropathy because both ATP andmito-
chondrial DNA contents in the kidney were similar to those of
the db/m-sham group. Increase in blood creatinine and urea nitro-
gen levels were also observed. However, these changes did not
reflect the severity of the nephropathy and might be attributed to
the decrease of glomerular filtration rate by 5/6 nephrectomy.
Oxidative stress is believed to be the cause of diabetic nephropa-
thy. ROS accumulating in mitochondria causes mitochondrial
respiratory dysfunction, mitochondrial respiratory dysfunction
further increases ROS (3). Since mitochondrial ROS is produced in
complexes I and III, these complexes are often investigated in
studies related to oxidative stress. Reports show that renal complex
III activity decreases in diabetic rats (6), whereas the protein
levels of renal complexes I and III increase in diabetic mice (8). Our
results indicate that the protein level of renal complex I increased
transiently in db/db mice, which is in agreement with the results of
Fig. 5. Activity of renal complexes I and IV (compared to bovine
mitochondrial complexes).
For the db/m-5/6Nx group, complex I activity decreased in 24-26 -
weeks- old animals (A) and complex IV activity decreased in each week
for the db/m-5/6Nx group (B) compared to the complex activity of
animals of the same age from the db/m-Sham group. For the db/db
group, complex I and IV activities decreased (C) and increased (D),
respectively compared to those of 13 week-old animals. Data are shown as
meansSD. N.S., not significant, **, p0.01. Data are shown as
meansSD. *, p0.05.
Fig. 6. Complex protein levels in the kidneys (compared to bovine
mitochondrial complexes).
Purified mitochondria were electrophoresed by BN-PAGE, analyzed by
western blotting, and protein levels were compared to those of animals of
the same age. Complex I and III protein levels decreased in 24-26
weeks of age for the db/m-5/6Nx group (A). For the db/db group, the
levels of complexes I (16 -17 weeks of age), II (21 weeks of age), III,
and IV (16-17 and 21 weeks of age) decreased compared to those at 13
weeks of age (B). N.S., not significant, *, p0.05 or **, p0.01. Data are
shown as meansSD. *, p0.05.
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other studies. In contrast, activities of complexes I and IV and
protein levels of complex I and III decreased in db/m-5/6Nx mice.
The decrease in complex IV activity was the earliest detected
change in the complexes, and therefore, complex IV was highly
susceptible to glomerular hyperfiltration among the mitochondrial
complexes. Investigating the activities of complexes II, III, and V in
db/m-5/6Nx mice would clarify the relationship between complex
IV and glomerular hyperfiltration. The activity of complex IV was
low throughout the time period of the study ; however, the com-
plex protein levels did not differ from that of the db/m-sham
group. The low activity level of complex IV is not due to low protein
levels, and the mechanism via which its levels are regulated in dia-
betic nephropathy is unknown. Cyan, an inhibitor of complex IV, is
known to promote ROS production (19). Similar to cyanogenesis,
reduction in the activity of complex IV in db/m-5/6Nx mice might
be due to be stimulation of ROS production.
In db/m-5/6Nx mice, complex IV activity decreased before the
decrease in complex I activity and reduction in complex I and III
protein levels. Mitochondrial respiratory chain was nonconcordant in
the kidney of the db/m-5/6Nx mouse, which is a model for
glomerular hyperfiltration.
CONCLUSION
In summary, mitochondrial complexes were nonconcordant in
the kidney of db/m-5/6Nx mice, a glomerular hyperfiltration
model. These results indicate that if glomerular hyperfiltration is
coupled with hypertension and diabetes, mitochondrial dysfunc-
tion and concomitant nephropathy may augment the severity of the
disease in addition to hyperglycemia-mediated mitochondrial
dysfunction. The kind of changed complexes were differences
between db/m-5/6Nxmice and db/db-mice. At present, we are
not understood sure whether this difference is due to hyperglyce-
mia, accumulated anemic toxins or the progression degree of the
clinical state. The pathogenesis of glomerular hyperfiltration in the
early stages of diabetic nephropathy and hypertensive nephropa-
thy requires further investigation.
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